Current and emerging therapeutic modalities for hyperhidrosis, part 1: conservative and noninvasive treatments.
Approximately 1% to 3% of the US population has hyperhidrosis (HH). HH can be an incapacitating medical condition because it not only hinders patient quality of life but also causes the secondary effect of excess cutaneous sweat. There is a broad spectrum of treatment modalities including topical and systemic therapies, iontophoresis, localized neuroinhibitory injections, and surgical interventions. This article reviews HH and the conservative treatments for the condition.
Cedars-Sinai Medical Center, Los Angeles, California, USA.
Ramin
R
Ram
Nicholas J
NJ
Lowe
Paul S
PS
Yamauchi
D000287:Administration, Topical; D017607:Aluminum Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D051520:Antiperspirants / Q000009:adverse effects / Q000627:therapeutic use*; D018680:Cholinergic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006945:Hyperhidrosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D007478:Iontophoresis; D015995:Prevalence; D013546:Sweating / Q000502:physiology
D017607:Aluminum Compounds; D051520:Antiperspirants; D018680:Cholinergic Antagonists